HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Orofacial granulomatosis treated with low-level laser therapy: a case report.

AbstractOBJECTIVES:
We report a case of orofacial granulomatosis successfully treated with low-level laser therapy (LLLT).
STUDY DESIGN:
LLLT was delivered through a diode laser device (Lasemar Eufoton, Trieste, Italy) with the use of a 4-cm defocalized lens and power of 1 W. Treatment was administered in sessions of 5 irradiations of 1 minute each, with a 1-minute interval between 2 subsequent irradiations (power density 0.08 W/cm(2); fluence/application: 4.8 J/cm(2); fluence/session: 24 J/cm(2)). Laser therapy was repeated 12 times (3 times per week).
RESULTS:
After 2 weeks of LLLT applications, the patient reported an improvement of symptomatology as well as a decrease of labial swelling. Complete healing was observed after 1 month. The patient was followed for 2 years. No recurrence of swelling was observed during the follow-up.
CONCLUSIONS:
Advantages of the LLLT approach include an absence of side effects, analgesic properties (usually reported after first application), and good patient compliance.
AuthorsElisabetta Merigo, Carlo Fornaini, Maddalena Manfredi, Marco Meleti, Federico Alberici, Luigi Corcione, Carlo Buzio, Jean-Paul Rocca, Teore Ferri, Paolo Vescovi
JournalOral surgery, oral medicine, oral pathology and oral radiology (Oral Surg Oral Med Oral Pathol Oral Radiol) Vol. 113 Issue 6 Pg. e25-9 (Jun 2012) ISSN: 2212-4411 [Electronic] United States
PMID22668714 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Topics
  • Granulomatosis, Orofacial (radiotherapy)
  • Humans
  • Lasers, Semiconductor (therapeutic use)
  • Low-Level Light Therapy
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: